Aging Overview

Aging gene

Gene name: PAPSS2
Aging type: Prevent
Aging characteristic:
Tissue type: Tumor tissue
Cell name: MCF-7
Gene ID: 9060
Category: protein coding
Phenotype: Breast cancer
Experimental category: HL
PMID: 26250908
Experiment: Cell morphological analysis//Colony formation assay//Flow cytometry//SA-β-gal activity assay
Description: MCF7 human breast cancer cells treated with PAPSS2 Si were fewer in number and showed poor colony-forming ability compared with control siRNA (Con Si)-transfected cells. PAPSS2-depleted cells accumulated in the G1 phase with no increase in the proportion of cells either in the subG1 phase or that were positive for propidium iodide staining. PAPSS2-depleted cells displayed hallmarks of senescent cells such as enlarged and flattened morphology and SA-β-Gal staining.As PAPSS2 was depleted, the cells showed a loss of phosphorylated pRb with changes of cell cycle regulatory protein levels and accumulation of p53 and p21.


Regulatory relationship

Regulatory pathway: FGFR-AKT-P53-P21
R-AG-Pathway: --
Official symbol(s): FGFR1-AKT1-TP53-CDKN1A
Pathway experiment: SA-β-gal activity assay//Western blot
Pathway description: PAPSS2-mediated premature senescence, including a loss of phosphorylated pRb, a decrease in cell number, and an increase in SA-β-Gal positivity, was blocked in both p53?/?and p21?/?HCT116 human colon cancer cells.We confirmed that P APSS2 depletion induced augmented FGFR/AKT activation and p53/p21 accumulation in both A549 and HDF cells . The overexpression of a kinase-inActivate (KI) mutant of FGFR1 (FGFR1-KI) attenuated AKT phosphorylation and p53/p21 accumulation in PAPSS2-depleted cells.


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.



Pathway view

About risk SNP and eQTL

Loading,please wait...